AAAAAA
Results: 1-25/103
Authors:
JORDAN VC
Citation: Vc. Jordan, PREVENTING BREAST-CANCER WITH TAMOXIFEN, Hospital practice, 33(9), 1998, pp. 59
Authors:
OREGAN RM
CISNEROS A
ENGLAND GM
MACGREGOR JI
MUENZNAR HD
ASSIKIS VJ
BILIMORIA MM
PIETTE M
DRAGAN YP
PITOT HC
CHATTERTON R
JORDAN VC
Citation: Rm. Oregan et al., EFFECTS OF THE ANTIESTROGENS TAMOXIFEN, TOREMIFENE, AND ICI-182,780 ON ENDOMETRIAL CANCER GROWTH, Journal of the National Cancer Institute, 90(20), 1998, pp. 1552-1558
Authors:
JORDAN VC
Citation: Vc. Jordan, ANTIESTROGENIC ACTION OF RALOXIFENE AND TAMOXIFEN - TODAY AND TOMORROW, Journal of the National Cancer Institute, 90(13), 1998, pp. 967-971
Authors:
DRAGAN YP
SHIMEL RJ
BAHNUB N
SATTLER G
VAUGHAN JR
JORDAN VC
PITOT HC
Citation: Yp. Dragan et al., EFFECT OF CHRONIC ADMINISTRATION OF MESTRANOL, TAMOXIFEN, AND TOREMIFENE ON HEPATIC PLOIDY IN RATS, TOXICOLOGICAL SCIENCES, 43(2), 1998, pp. 129-138
Authors:
ENGLAND GM
BILIMORIA MM
CHEN ZH
ASSIKIS VJ
MUENZNER HD
JORDAN VC
Citation: Gm. England et al., CHARACTERIZATION OF A POINT MUTATION IN THE HORMONE-BINDING DOMAIN OFTHE ESTROGEN-RECEPTOR FROM AN ESTROGEN-INDEPENDENT BREAST-TUMOR, International journal of oncology, 12(5), 1998, pp. 981-986
Authors:
TONETTI DA
OREGAN R
TANJORE S
ENGLAND G
JORDAN VC
Citation: Da. Tonetti et al., ANTIESTROGEN STIMULATED HUMAN ENDOMETRIAL CANCER GROWTH - LABORATORY AND CLINICAL CONSIDERATIONS, Journal of steroid biochemistry and molecular biology, 65(1-6), 1998, pp. 181-189
Authors:
JORDAN VC
Citation: Vc. Jordan, CHEMOTHERAPY IS ANTIHORMONAL THERAPY - HOW MUCH PROOF DO ONCOLOGISTS NEED, European journal of cancer, 34(5), 1998, pp. 606-608
Authors:
JORDAN VC
Citation: Vc. Jordan, TAMOXIFEN AND UTERINE-CANCER - CONFOUNDING VARIABLES, European journal of cancer, 34, 1998, pp. 50-51
Authors:
OREGAN R
CISNEROS A
JORDAN VC
Citation: R. Oregan et al., IS THERE LIFE AFTER TAMOXIFEN - NEW ANTIESTROGENS, European journal of cancer, 34, 1998, pp. 57-58
Authors:
JORDAN VC
Citation: Vc. Jordan, THE MOLECULAR-BIOLOGY OF THE ESTROGEN-RECEPTOR (ER) AIDS IN THE UNDERSTANDING OF TAMOXIFEN RESISTANCE AND BREAST-CANCER PREVENTION WITH RALOXIFENE, European journal of cancer, 34, 1998, pp. 26-26
Authors:
FLOREN LC
HEBERT MF
VENOOK AP
JORDAN VC
CISNEROS A
SOMBERG KA
Citation: Lc. Floren et al., TAMOXIFEN IN LIVER-DISEASE - POTENTIAL EXACERBATION OF HEPATIC-DYSFUNCTION, Annals of oncology, 9(10), 1998, pp. 1123-1126
Authors:
LEVENSON AS
SVOBODA KM
KWAAN HC
JORDAN VC
Citation: As. Levenson et al., AGONIST ACTIVITY OF ANTIESTROGEN-RECEPTOR COMPLEXES TO REGULATE UROKINASE PLASMINOGEN-ACTIVATOR (UPA) AND PLASMINOGEN-ACTIVATOR INHIBITOR TYPE-I (PAI-1) ENDOGENOUS GENE-EXPRESSION IN BREAST-CANCER CELLS, Cancer letters, 125(1-2), 1998, pp. 215-220
Authors:
JORDAN VC
Citation: Vc. Jordan, DESIGNER ESTROGENS, Scientific American, 279(4), 1998, pp. 60-67
Authors:
MACGREGOR JI
JORDAN VC
Citation: Ji. Macgregor et Vc. Jordan, BASIC GUIDE TO THE MECHANISMS OF ANTIESTROGEN ACTION, Pharmacological reviews, 50(2), 1998, pp. 151-196
Authors:
ANDERSON T
BARDIN CW
BARRETTCONNER E
BLACK C
BORWHAT M
BURGER H
CLARKSON T
COBLEIGH M
COSMAN F
HAYES H
DOUGLAS MS
DUNAIF A
FORD J
GANZ P
GLEASON S
GOODWIN P
GOSS P
GREEN B
GRETZ E
HARVEY J
HAZZARD W
HELZLSOUER K
JORDAN VC
JOSSE R
KELEGHAN J
KLEEREKOPER M
LEWIS J
LLEWELLYNTHOMAS H
LOPRINZI C
MARK M
MARTIN A
MARTIN H
MIESFELDT S
MOORE M
NACHTIGALL L
NEW M
OCONNOR A
OLSEN M
PARKER B
PARNES H
PERLMAN J
PINKERTON J
POWLES T
PRIOR J
PRITCHARD K
RAGAZ J
RAILEY E
KOMEN SG
RUMEN N
ROPKA M
ROSS RK
SANTEN R
SAWKA C
SELLIN R
SLINGLUFF C
SWAIN S
TYSENHOUSE P
WATTS N
WHAMOND E
WILLS M
Citation: T. Anderson et al., TREATMENT OF ESTROGEN DEFICIENCY SYMPTOMS IN WOMEN SURVIVING BREAST-CANCER, The Journal of clinical endocrinology and metabolism, 83(6), 1998, pp. 1993-2000
Authors:
LEVENSON AS
JORDAN VC
Citation: As. Levenson et Vc. Jordan, THE KEY TO THE ANTIESTROGENIC MECHANISM OF RALOXIFENE IS AMINO-ACID 351 (ASPARTATE) IN THE ESTROGEN-RECEPTOR, Cancer research, 58(9), 1998, pp. 1872-1875
Authors:
LEVENSON AS
KWAAN HC
SVOBODA KM
WEISS IM
SAKURAI S
JORDAN VC
Citation: As. Levenson et al., ESTRADIOL REGULATION OF THE COMPONENTS OF THE PLASMINOGEN-PLASMIN SYSTEM IN MDA-MB-231 HUMAN BREAST-CANCER CELLS STABLY EXPRESSING THE ESTROGEN-RECEPTOR, British Journal of Cancer, 78(1), 1998, pp. 88-95
Authors:
CHEN Z
KO A
YANG J
JORDAN VC
Citation: Z. Chen et al., METHYLATION OF CPG ISLAND IS NOT A UBIQUITOUS MECHANISM FOR THE LOSS OF ESTROGEN-RECEPTOR IN BREAST-CANCER CELLS, British Journal of Cancer, 77(2), 1998, pp. 181-185
Authors:
NUWAYSIR EF
DRAGAN YP
MCCAGUE R
MARTIN P
MANN J
JORDAN VC
PITOT HC
Citation: Ef. Nuwaysir et al., STRUCTURE-ACTIVITY-RELATIONSHIPS FOR TRIPHENYLETHYLENE ANTIESTROGENS ON HEPATIC PHASE-I AND PHASE-II ENZYME EXPRESSION, Biochemical pharmacology, 56(3), 1998, pp. 321-327
Authors:
JORDAN VC
Citation: Vc. Jordan, TAMOXIFEN - THE HERALD OF A NEW ERA OF PREVENTIVE THERAPEUTICS, Journal of the National Cancer Institute, 89(11), 1997, pp. 747-749
Authors:
POLLACK IF
DAROSSO RC
ROBERTSON PL
JAKACKI RL
MIRRO JR
BLATT J
NICHOLSON S
PACKER RJ
ALLEN JC
CISNEROS A
JORDAN VC
Citation: If. Pollack et al., A PHASE-I STUDY OF HIGH-DOSE TAMOXIFEN FOR THE TREATMENT OF REFRACTORY MALIGNANT GLIOMAS OF CHILDHOOD, Clinical cancer research, 3(7), 1997, pp. 1109-1115
Authors:
JORDAN VC
Citation: Vc. Jordan, AFTER THE MENOPAUSE - TAMOXIFEN AND OTHER NEW PREVENTION MAINTENANCE THERAPIES, Journal of women's health, 6(3), 1997, pp. 257-259
Authors:
ENGLAND GM
JORDAN VC
Citation: Gm. England et Vc. Jordan, PURE ANTIESTROGENS AS A NEW THERAPY FOR BREAST-CANCER, Oncology research, 9(8), 1997, pp. 397-402
Authors:
TONETTI DA
JORDAN VC
Citation: Da. Tonetti et Vc. Jordan, THE ROLE OF ESTROGEN-RECEPTOR MUTATIONS IN TAMOXIFEN-STIMULATED BREAST-CANCER, Journal of steroid biochemistry and molecular biology, 62(2-3), 1997, pp. 119-128
Authors:
LEVENSON AS
CATHERINO WH
JORDAN VC
Citation: As. Levenson et al., ESTROGENIC ACTIVITY IS INCREASED FOR AN ANTIESTROGEN BY A NATURAL MUTATION OF THE ESTROGEN-RECEPTOR, Journal of steroid biochemistry and molecular biology, 60(5-6), 1997, pp. 261-268